Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETA trial of intranasal ketamine for acute suicidality
NL-OMON52646Phase 2Completed
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in suicidal ideation and Suicidality comparing Intranasal ketamine with Intranasal midazolam active placebo (2 arms). Primary endpoint: Change in Beck Scale for Suicide Ideation score at 180 minutes. Started Aug 2021; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
suicidal ideationSuicidality
Beyond the preview
Go deeper on NL-OMON52646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52646.